Potentiation of isoniazid activity against Mycobacterium tuberculosis by melatonin

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 4, 1999, Pages 975-977

  Wiid, Ian ^a   Hoal Van Helden, Eileen ^a   Hon, Dinie ^a   Lombard, Carl ^a   Van Helden, Paul ^a,b  

^a SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^b STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; MELATONIN;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; CHEMOTHERAPY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; HUMAN; HUMAN CELL; MYCOBACTERIUM TUBERCULOSIS; PINEAL BODY; PRIORITY JOURNAL; TUBERCULOSIS CONTROL;

EID: 0032891565     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.4.975     Document Type: Article

References (19)

1. Barrett, B. K., L. Newbolt, and S. Edwards. 1994. The membrane destabilising action of the antibacterial agent chlorohexidine. FEMS Microbiol. Lett. 119:249-253.
2. Ben-Nathan, D., G. J. M. Maestroni, and A. Conti. 1997. The protective effect of melatonin in viral and bacterial infections, p. 71-80. In G. J. M. Maestroni, A. Conti, and R. J. Reiter (ed.). Therapeutic potential of melatonin. Karger, Basel, Switzerland.
3. Ben-Nathan, D., G. J. M. Maestroni, S. Lustig, and A. Conti. 1995. Protective effect of melatonin in mice infected with encephalitis virus. Arch. Virol. 140:223-230.
4. Bredt, D. S., and S. H. Snyder. 1994. Nitric oxide: a physiologic messenger molecule. Annu. Rev. Biochem. 53:175-195.
5. Brezezinski, A. 1997. Melatonin in humans. N. Engl. J. Med. 336:186-195.
6. Cressie, N. A. C. 1991. Statistics for spatial data. John Wiley & Sons, Inc., New York, N.Y.
7. Ellis, L. C. 1996. Melatonin reduces mortality from alcutian disease in mink (Mustela vison). J. Pineal Res. 21:214-217.
8. Goodwin, D. C., S. D. Aust, and T. A. Grover. 1996. Free radicals produced during the oxidation of hydraxines by hypochlorous acid. Chem. Res. Toxicol. 9:1333-1339.
9. Guerrero, J. M., and R. J. Reiter. 1992. A brief survey of pineal gland-immune system interrelationships. Endocr. Res. 18:91-113.
10. Kent, P. T., and G. P. Kubica. 1985. A guide for the level III laboratory, p. 81-82. Centers for Disease Control. Atlanta, Ga.
11. Lin, J. Y., and K. Chadee. 1992. Macrophage cytotoxicity against Entamoeba histolytica trophozoites is mediated hy nitric oxide from L-arginine. J. Immunol. 141:3999-4004.
12. Melchiorri, D., R. J. Reiter, A. M. Attia, M. Hara, M. Burgos, and G. Nistico. 1995. Potent protective effect of melatonin on in vivo paraquat-induced oxidative damage in rats. Life Sci. 56:83-89.
13. Meyers, P. R., W. R. Bourn, L. M. Steyn, P. D. van Helden, A. D. Beyers, and G. D. Brown. 1998. Novel method for rapid measurement of growth of mycobacteria in detergent-free media. J. Clin. Microbiol. 36:2752-2754.
14. Middlebrook, G. 1977. Automatable radiometric detection in growth of Mycobacterium tuberculosis in selective media. Annu. Rev. Respir. Dis. 115: 1066-1069.
15. Morrey, K. M., J. M. McLachlan, C. D. Serkin, and O. Bakouche. 1994. Activation of human monocytes by the pineal hormone melatonin. J. Immunol. 153:2671-2680.
16. Reiter, R. J. Antioxidant action of melatonin. 1997. Adv. Pharmacol. 38:103-117.
17. Reiter, R. J., L. Tang, J. J. Garcia, and A. Munoz-Hoyos. 1997. Pharmacological actions of melatonin in oxygen radical pathophysiology. Life Sci. 60:2255-2271.
18. Reiter, R. J., R. C. Carneiro, C. S. Oh. 1997. Melatonin in relation to cellular antioxidative defense mechanisms. Horm. Metab. Res. 29:363-372.
19. Siddiqui, S. H. 1995. BACTEC 460 TB system. Product and procedure manual. Becton Dickinson and Co., Sparks, Md.